New β-lactamase inhibitors: a therapeutic renaissance in an MDR world
SM Drawz, KM Papp-Wallace… - Antimicrobial agents and …, 2014 - Am Soc Microbiol
As the incidence of Gram-negative bacterial infections for which few effective treatments
remain increases, so does the contribution of drug-hydrolyzing β-lactamase enzymes to this …
remain increases, so does the contribution of drug-hydrolyzing β-lactamase enzymes to this …
[引用][C] New β-Lactamase Inhibitors: a Therapeutic Renaissance in an MDR World
SM DRAWZ, KM PAPP-WALLACE… - Antimicrobial agents …, 2014 - pascal-francis.inist.fr
New β-Lactamase Inhibitors: a Therapeutic Renaissance in an MDR World CNRS Inist
Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search Advanced …
Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search Advanced …
New β-lactamase inhibitors: a therapeutic renaissance in an MDR world.
SM Drawz, KM Papp-Wallace… - Antimicrobial Agents and …, 2013 - europepmc.org
As the incidence of Gram-negative bacterial infections for which few effective treatments
remain increases, so does the contribution of drug-hydrolyzing β-lactamase enzymes to this …
remain increases, so does the contribution of drug-hydrolyzing β-lactamase enzymes to this …
[PDF][PDF] New-Lactamase Inhibitors: a Therapeutic Renaissance in an MDR World
SM Drawz, KM Papp-Wallace, RA Bonomob - 2014 - researchgate.net
As the incidence of Gram-negative bacterial infections for which few effective treatments
remain increases, so does the contribution of drug-hydrolyzing ß-lactamase enzymes to this …
remain increases, so does the contribution of drug-hydrolyzing ß-lactamase enzymes to this …
[HTML][HTML] New β-Lactamase Inhibitors: a Therapeutic Renaissance in an MDR World
SM Drawz, KM Papp-Wallace… - Antimicrobial Agents and …, 2014 - ncbi.nlm.nih.gov
As the incidence of Gram-negative bacterial infections for which few effective treatments
remain increases, so does the contribution of drug-hydrolyzing β-lactamase enzymes to this …
remain increases, so does the contribution of drug-hydrolyzing β-lactamase enzymes to this …
New β-lactamase inhibitors: a therapeutic renaissance in an MDR world.
SM Drawz, KM Papp-Wallace… - Antimicrobial Agents and …, 2014 - cabdirect.org
As the incidence of Gram-negative bacterial infections for which few effective treatments
remain increases, so does the contribution of drug-hydrolyzing β-lactamase enzymes to this …
remain increases, so does the contribution of drug-hydrolyzing β-lactamase enzymes to this …
New β-lactamase inhibitors: a therapeutic renaissance in an MDR world
SM Drawz, KM Papp-Wallace… - Antimicrobial agents …, 2014 - pubmed.ncbi.nlm.nih.gov
As the incidence of Gram-negative bacterial infections for which few effective treatments
remain increases, so does the contribution of drug-hydrolyzing β-lactamase enzymes to this …
remain increases, so does the contribution of drug-hydrolyzing β-lactamase enzymes to this …
New β-lactamase inhibitors: A therapeutic renaissance in an MDR world
SM Drawz, KM Papp-Wallace… - Antimicrobial agents and …, 2014 - experts.umn.edu
As the incidence of Gram-negative bacterial infections for which few effective treatments
remain increases, so does the contribution of drug-hydrolyzing β-lactamase enzymes to this …
remain increases, so does the contribution of drug-hydrolyzing β-lactamase enzymes to this …
New β-lactamase inhibitors: a therapeutic renaissance in an MDR world.
SM Drawz, KM Papp-Wallace… - Antimicrobial Agents and …, 2013 - europepmc.org
As the incidence of Gram-negative bacterial infections for which few effective treatments
remain increases, so does the contribution of drug-hydrolyzing β-lactamase enzymes to this …
remain increases, so does the contribution of drug-hydrolyzing β-lactamase enzymes to this …